• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five Forces Summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Distribution channel
o Market segments
o Comparison by Distribution channel
o Retail – Market size and forecast 2019-2024
o Online – Market size and forecast 2019-2024
o Market opportunity by Distribution channel
• Customer landscape
o Overview
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o Asia – Market size and forecast 2019-2024
o ROW – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Volume drivers – Demand led growth
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Amway Corp.
o Abbott Laboratories
o Archer Daniels Midland Co.
o Arkopharma Laboratories
o BASF SE
o Bayer AG
o Glanbia Plc
o GNC Holdings Inc.
o Hi-Tech Pharmaceuticals Inc.
o Koninklijke DSM NV
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2019 – 2024 ($ million)
• 13: Global market: Year-over-year growth 2019 – 2024 (%)
• 14: Five forces analysis 2019 & 2024
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2019
• 21: Distribution channel – Market share 2019-2024 (%)
• 22: Comparison by Distribution channel
• 23: Retail – Market size and forecast 2019-2024 ($ million)
• 24: Retail – Year-over-year growth 2019-2024 (%)
• 25: Online – Market size and forecast 2019-2024 ($ million)
• 26: Online – Year-over-year growth 2019-2024 (%)
• 27: Market opportunity by Distribution channel
• 28: Customer landscape
• 29: Market share by geography 2019-2024 (%)
• 30: Geographic comparison
• 31: North America – Market size and forecast 2019-2024 ($ million)
• 32: North America – Year-over-year growth 2019-2024 (%)
• 33: Europe – Market size and forecast 2019-2024 ($ million)
• 34: Europe – Year-over-year growth 2019-2024 (%)
• 35: Asia – Market size and forecast 2019-2024 ($ million)
• 36: Asia – Year-over-year growth 2019-2024 (%)
• 37: ROW – Market size and forecast 2019-2024 ($ million)
• 38: ROW – Year-over-year growth 2019-2024 (%)
• 39: Key leading countries
• 40: Market opportunity by geography ($ million)
• 41: Impact of drivers and challenges
• 42: Vendor landscape
• 43: Landscape disruption
• 44: Industry risks
• 45: Vendors covered
• 46: Market positioning of vendors
• 47: Amway Corp. – Overview
• 48: Amway Corp. – Product and service
• 49: Amway Corp. – Key offerings
• 50: Amway Corp. – Key customers
• 51: Amway Corp. – Segment focus
• 52: Abbott Laboratories – Overview
• 53: Abbott Laboratories – Business segments
• 54: Abbott Laboratories – Key offerings
• 55: Abbott Laboratories – Key customers
• 56: Abbott Laboratories – Segment focus
• 57: Archer Daniels Midland Co. – Overview
• 58: Archer Daniels Midland Co. – Business segments
• 59: Archer Daniels Midland Co. – Key offerings
• 60: Archer Daniels Midland Co. – Key customers
• 61: Archer Daniels Midland Co. – Segment focus
• 62: Arkopharma Laboratories – Overview
• 63: Arkopharma Laboratories – Product and service
• 64: Arkopharma Laboratories – Key offerings
• 65: Arkopharma Laboratories – Key customers
• 66: Arkopharma Laboratories – Segment focus
• 67: BASF SE – Overview
• 68: BASF SE – Business segments
• 69: BASF SE – Key offerings
• 70: BASF SE – Key customers
• 71: BASF SE – Segment focus
• 72: Bayer AG – Overview
• 73: Bayer AG – Business segments
• 74: Bayer AG – Key offerings
• 75: Bayer AG – Key customers
• 76: Bayer AG – Segment focus
• 77: Glanbia Plc – Overview
• 78: Glanbia Plc – Business segments
• 79: Glanbia Plc – Key offerings
• 80: Glanbia Plc – Key customers
• 81: Glanbia Plc – Segment focus
• 82: GNC Holdings Inc. – Overview
• 83: GNC Holdings Inc. – Business segments
• 84: GNC Holdings Inc. – Key offerings
• 85: GNC Holdings Inc. – Key customers
• 86: GNC Holdings Inc. – Segment focus
• 87: Hi-Tech Pharmaceuticals Inc. – Overview
• 88: Hi-Tech Pharmaceuticals Inc. – Product and service
• 89: Hi-Tech Pharmaceuticals Inc. – Key offerings
• 90: Hi-Tech Pharmaceuticals Inc. – Key customers
• 91: Hi-Tech Pharmaceuticals Inc. – Segment focus
• 92: Koninklijke DSM NV – Overview
• 93: Koninklijke DSM NV – Business segments
• 94: Koninklijke DSM NV – Key offerings
• 95: Koninklijke DSM NV – Key customers
• 96: Koninklijke DSM NV – Segment focus
• 97: Currency conversion rates for US$
• 98: Research Methodology
• 99: Validation techniques employed for market sizing
• 100: Information sources
• 101: List of abbreviations
【掲載企業】
Amway Corp., Abbott Laboratories, Archer Daniels Midland Co., Arkopharma Laboratories, BASF SE, Bayer AG, Glanbia Plc, GNC Holdings Inc., Hi-Tech Pharmaceuticals Inc., Koninklijke DSM NV
【免責事項】
https://www.marketreport.jp/reports-disclaimer